Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2024-01-02 00:00:00 ET · period of report 2023-12-27 · accession 0000950170-24-000428 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-02 | 2023-12-27 | KLRS | Hagen Brett R | CAO | S - Sale | $0.74 | -28.3K | 97.5K | -23% | -$21.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | S | D | 28,335 | $0.74 | 97,500 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7228 to $0.7452. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |